Company insider dossier

Heron Therapeuti insider intelligence

HRTX filings assessed for conviction, transaction quality, insider breadth, clustering, freshness, and price confirmation.

Terminal chart Weekly report Factor intelligence Healthcare Biotechnology Data API
17/100

Concentrated distribution

51/100 confidence
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Latest evidence
6 Aug 2026

Investment committee read

Concentrated distribution

Priced common-share disposals are concentrated enough to warrant review, but they are not treated as a standalone bearish forecast.

Review exposure and filing context

Evidence in favour

  • Participation spans 4 named insiders rather than one filing source.

Decision risks

  • Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.
  • Most filings are awards, derivatives, unpriced common shares, or other securities and remain contextual.
  • The latest qualifying filing is more than 30 days old.
Conviction17Concentrated distribution
Confidence51Developing
Named insiders4participating in the tape
Controlled events6directional common-share events
Acquisition value$0normalized amount
Disposal value$13.8Knormalized amount

Price confirmation map

Weekly price with common-share events

Acquisitions and disposals are aligned to the nearest completed weekly bar.

2.311.811.310.810.31 Acquisition · 6 Aug 2026 · Not reportedDisposal · 6 Aug 2026 · $4.4KAcquisition · 31 Jul 2026 · Not reportedAcquisition · 31 Jul 2026 · Not reportedAcquisition · 31 Jul 2026 · Not reportedAcquisition · 31 Jul 2026 · Not reportedDisposal · 31 Jul 2026 · $1.7KDisposal · 31 Jul 2026 · $1.7KAcquisition · 30 Jul 2026 · Not reportedAcquisition · 30 Jul 2026 · Not reportedAcquisition · 30 Jul 2026 · Not reportedDisposal · 30 Jul 2026 · $1.9KDisposal · 30 Jul 2026 · $1.7KAcquisition · 19 Jul 2026 · Not reportedAcquisition · 19 Jul 2026 · Not reportedAcquisition · 19 Jul 2026 · Not reportedDisposal · 19 Jul 2026 · $517Disposal · 19 Jul 2026 · $517Acquisition · 16 Jun 2026 · Not reportedDisposal · 16 Jun 2026 · $1.4KAcquisition · 6 Jun 2026 · Not reportedAcquisition · 6 May 2026 · Not reportedAcquisition · 30 Apr 2026 · Not reportedAcquisition · 30 Apr 2026 · Not reportedAcquisition · 30 Apr 2026 · Not reportedAcquisition · 30 Apr 2026 · Not reportedAcquisition · 30 Apr 2026 · Not reportedAcquisition · 30 Apr 2026 · Not reportedAcquisition · 30 Apr 2026 · Not reportedAcquisition · 19 Apr 2026 · Not reportedAcquisition · 19 Apr 2026 · Not reportedAcquisition · 19 Apr 2026 · Not reported
Mar 2025Sep 2026
Weekly closeCommon-share acquisitionCommon-share disposal

Market confirmation

Price and trend context

Latest close
0.3097 USD
One-week move
-1.8%
Four-week move
-2.7%
Fair-value gap
-81.4%
Trend signal
Inactive
Relative strength
-70.3

Directional balance

Controlled event mix

0.0%acquisition
Acquisition events
0
Disposal events
6
Net value
-$13.8K

Cadence

Twelve-week filing pressure

Volume shows attention. Controlled events determine direction.

029 Jun
006 Jul
813 Jul
020 Jul
1827 Jul
303 Aug
010 Aug
017 Aug
024 Aug
031 Aug
007 Sep
014 Sep

Named participants

Insider conviction by person

COLLARD, CRAIG ADirector, Chief Executive Officer500 events
HENSLEY, MARK EARLChief Operating Officer281 events
FORBES, WILLIAM PEVP, Chief Development Officer223 events
DUARTE, IRAEVP, Chief Financial Officer204 events

Evidence quality

Security and transaction context

Common equity32
Equity compensation24
Options and derivatives0
Other securities0

Role architecture

Who is participating

Other executive26
Finance leadership18
CEO and chair12

Transaction evidence

Auditable HRTX filing ledger

Showing 1 to 30 of 56.

HENSLEY, MARK EARLChief Operating Officer
DisposalEquity compensation
31250 sharesRestricted Stock Units
Not reportedContext evidence
HENSLEY, MARK EARLChief Operating Officer
AcquisitionCommon equity
31250 sharesCommon Stock
Not reportedContext evidence
HENSLEY, MARK EARLChief Operating Officer
DisposalCommon equity
8888 sharesCommon Stock
$4.4KDirectional evidence
COLLARD, CRAIG ADirector, Chief Executive Officer
AcquisitionCommon equity
34789 sharesCommon Stock
Not reportedContext evidence
COLLARD, CRAIG ADirector, Chief Executive Officer
DisposalEquity compensation
34789 sharesRestricted Stock Units
Not reportedContext evidence
DUARTE, IRAEVP, Chief Financial Officer
AcquisitionCommon equity
11694 sharesCommon Stock
Not reportedContext evidence
DUARTE, IRAEVP, Chief Financial Officer
DisposalEquity compensation
11694 sharesRestricted Stock Units
Not reportedContext evidence
FORBES, WILLIAM PEVP, Chief Development Officer
AcquisitionCommon equity
11694 sharesCommon Stock
Not reportedContext evidence
FORBES, WILLIAM PEVP, Chief Development Officer
DisposalEquity compensation
11694 sharesRestricted Stock Units
Not reportedContext evidence
HENSLEY, MARK EARLChief Operating Officer
DisposalEquity compensation
11769 sharesRestricted Stock Units
Not reportedContext evidence
HENSLEY, MARK EARLChief Operating Officer
AcquisitionCommon equity
11769 sharesCommon Stock
Not reportedContext evidence
DUARTE, IRAEVP, Chief Financial Officer
DisposalCommon equity
3326 sharesCommon Stock
$1.7KDirectional evidence
FORBES, WILLIAM PEVP, Chief Development Officer
DisposalCommon equity
3326 sharesCommon Stock
$1.7KDirectional evidence
COLLARD, CRAIG ADirector, Chief Executive Officer
DisposalEquity compensation
50021 sharesRestricted Stock Units
Not reportedContext evidence
COLLARD, CRAIG ADirector, Chief Executive Officer
AcquisitionCommon equity
50021 sharesCommon Stock
Not reportedContext evidence
DUARTE, IRAEVP, Chief Financial Officer
AcquisitionCommon equity
13535 sharesCommon Stock
Not reportedContext evidence
DUARTE, IRAEVP, Chief Financial Officer
DisposalEquity compensation
13535 sharesRestricted Stock Units
Not reportedContext evidence
FORBES, WILLIAM PEVP, Chief Development Officer
DisposalEquity compensation
11769 sharesRestricted Stock Units
Not reportedContext evidence
FORBES, WILLIAM PEVP, Chief Development Officer
AcquisitionCommon equity
11769 sharesCommon Stock
Not reportedContext evidence
DUARTE, IRAEVP, Chief Financial Officer
DisposalCommon equity
3850 sharesCommon Stock
$1.9KDirectional evidence
FORBES, WILLIAM PEVP, Chief Development Officer
DisposalCommon equity
3348 sharesCommon Stock
$1.7KDirectional evidence
COLLARD, CRAIG ADirector, Chief Executive Officer
DisposalEquity compensation
13797 sharesRestricted Stock Units
Not reportedContext evidence
COLLARD, CRAIG ADirector, Chief Executive Officer
AcquisitionCommon equity
13797 sharesCommon Stock
Not reportedContext evidence
DUARTE, IRAEVP, Chief Financial Officer
AcquisitionCommon equity
3874 sharesCommon Stock
Not reportedContext evidence
DUARTE, IRAEVP, Chief Financial Officer
DisposalEquity compensation
3874 sharesRestricted Stock Units
Not reportedContext evidence
FORBES, WILLIAM PEVP, Chief Development Officer
DisposalEquity compensation
3874 sharesRestricted Stock Units
Not reportedContext evidence
FORBES, WILLIAM PEVP, Chief Development Officer
AcquisitionCommon equity
3874 sharesCommon Stock
Not reportedContext evidence
DUARTE, IRAEVP, Chief Financial Officer
DisposalCommon equity
1101 sharesCommon Stock
$517Directional evidence
FORBES, WILLIAM PEVP, Chief Development Officer
DisposalCommon equity
1101 sharesCommon Stock
$517Directional evidence
DUARTE, IRAEVP, Chief Financial Officer
AcquisitionCommon equity
12500 sharesCommon Stock
Not reportedContext evidence

Reading the dossier

Direction and confidence are separate

Conviction

The 0 to 100 score classifies deduplicated priced common-share evidence. Fifty is balanced or non-directional.

Confidence

Confidence rises with controlled event depth, named-insider breadth, fresh evidence, normalized values, and a longer observation span.

Disposals

Selling is not treated as the mirror image of buying. It carries less directional weight because taxes, diversification, compensation, and planned transactions can all create sales.

Price confirmation

The market chart tests whether the filing thesis is being confirmed or rejected by price, fair-value position, relative strength, and the current trend state.

Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.

Evidence context